Insmed | Driftskostnader

2022Q32023Q32024Q3

	Operating Expenses	Endring		Dato
BioMarin Pharmaceutical	USD 585.91M		45.94M	2024-12
Cytokinetics	USD 155.97M		14.7M	2024-12
DBV Technologies	USD 31.4M		3.6M	2024-09
Dynavax Technologies	USD 73.66M		3.12M	2024-12
Gilead Sciences	USD 5.12B		1.54B	2024-12
Insmed	USD 334.86M		28M	2024-12
Novartis	USD 10.15B		579M	2024-12
Regeneron Pharmaceuticals	USD 2.8B		26.53B	2024-12
Sarepta Therapeutics	USD 496.73M		51.76M	2024-12
Ultragenyx Pharmaceutical	USD 287.15M		15.67M	2024-12
Vertex Pharmaceuticals	USD 1.89B		230.4M	2024-12

Insmed Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.